Literature DB >> 30097703

[Osteomalacia-Clinical aspects, diagnostics and treatment].

M Tiefenbach1, M Scheel2, A Maier3, M Gehlen4, M Schwarz-Eywill4, M Werner5, U Siebers-Renelt6, M Hammer3.   

Abstract

Osteomalacia is a bone disease caused by impaired skeletal mineralization. Vitamin D dependent types have to be distinguished from hypophosphatemic forms. Typical signs and symptoms include diffuse bone pain, muscle weakness and fragility fractures. The fracture pattern in osteomalacia is typically different from that of osteoporosis. Fragility fractures of the pelvis, sacrum, distal parts of the foot, proximal tibia and ribs are indicators for osteomalacia, whereas femoral neck and vertebral fractures (wedged vertebra, fish vertebra, vertebra plana and cover plate impression fractures) are typical for osteoporosis. Unspecific clinical features may be the reason for a delayed diagnosis. The correct classification of the complaint is dependent on the knowledge of the pathophysiology of osteomalacia and performance of additional bone-specific examinations. Determination of specific laboratory parameters should follow a rational algorithm, supplemented by imaging methods and a bone biopsy.

Entities:  

Keywords:  Hypocalcemia; Hypophosphatemia; Imaging; Laboratory parameters; Vitamin D

Mesh:

Substances:

Year:  2018        PMID: 30097703     DOI: 10.1007/s00393-018-0510-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  38 in total

1.  Dynamometer measurements of hand-grip strength predict multiple outcomes.

Authors:  R W Bohannon
Journal:  Percept Mot Skills       Date:  2001-10

Review 2.  The roles of vitamin D in skeletal muscle: form, function, and metabolism.

Authors:  Christian M Girgis; Roderick J Clifton-Bligh; Mark W Hamrick; Michael F Holick; Jenny E Gunton
Journal:  Endocr Rev       Date:  2012-11-20       Impact factor: 19.871

3.  Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.

Authors:  Gabriela Dumitrescu; Catalina Mihai; Mihaela Dranga; Cristina Cijevschi Prelipcean
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

4.  Transiliac bone biopsy. Complications and diagnostic value.

Authors:  S D Rao; V Matkovic; H Duncan
Journal:  Henry Ford Hosp Med J       Date:  1980

5.  The epidemiology of osteoporosis--Bone Evaluation Study (BEST): an analysis of routine health insurance data.

Authors:  Peyman Hadji; Silvia Klein; Holger Gothe; Bertram Häussler; Thomas Kless; Torsten Schmidt; Thomas Steinle; Frank Verheyen; Roland Linder
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

6.  HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.

Authors:  Mario Cozzolino; Marcos Vidal; Maria Vittoria Arcidiacono; Pablo Tebas; Kevin E Yarasheski; Adriana S Dusso
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

7.  Noninvasive testing in the diagnosis of osteomalacia.

Authors:  C T Bingham; L A Fitzpatrick
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

Review 8.  Effectiveness and safety of vitamin D in relation to bone health.

Authors:  Ann Cranney; Tanya Horsley; Siobhan O'Donnell; Hope Weiler; Lorri Puil; Daylily Ooi; Stephanie Atkinson; Leanne Ward; David Moher; David Hanley; Manchung Fang; Fatemeh Yazdi; Chantelle Garritty; Margaret Sampson; Nick Barrowman; Alex Tsertsvadze; Vasil Mamaladze
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2007-08

9.  Vitamin D dependent rickets type I.

Authors:  Chan Jong Kim
Journal:  Korean J Pediatr       Date:  2011-02-28

10.  Influence of drugs on vitamin D and calcium metabolism.

Authors:  Uwe Gröber; Klaus Kisters
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more
  1 in total

Review 1.  Bioengineered Living Bone Grafts-A Concise Review on Bioreactors and Production Techniques In Vitro.

Authors:  Paulina Kazimierczak; Agata Przekora
Journal:  Int J Mol Sci       Date:  2022-02-03       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.